Other languages Psyence Group Inc.

Equities

PSYG

CA74449Q1063

Market Closed - Canadian Securities Exchange Other stock markets 11:18:24 27/06/2024 pm IST			5-day change	1st Jan Change
0.01 ^CAD	0.00%		-50.00%	-80.00%

26/03	Psyence Group Closes Strategic Restructuring of Its Non-Clinical Business	MT
26/03	An undisclosed buyer completed the acquisition of Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc..	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

An undisclosed buyer completed the acquisition of Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc..	26/03
Psyence Group Inc. Announces Resignation of Neil Maresky as CEO	11/03
Psyence Group Inc. Announces Board Resignations	11/03
Psyence Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	28/02
Psyence Group Inc. Announces Resignation of Marvin Singer as Board Member	21/11
Psyence Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11/11
Psyence Group Inc. Designs New Laboratory at Facility in Order to Expand its Extraction Capabilities	30/23/30
Psyence Group Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	29/23/29
Psyence Group Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	28/23/28
Psyence Group Inc. Appoints Christopher Bull to Board of Directors	11/23/11
Psyence Group Inc. Partners with iNGEN for Palliative Care Clinical Trial in Australia	21/23/21
Psyence Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	01/23/01
Psyence Group Inc. and Eden Labs LLC Announces Extraction and Product Development Collaboration	24/23/24
Psyence Group Inc. Appoints AC Braddock to Scientific Advisory Board	24/23/24
Psyence Group Completes Export of Pharma Grade Psilocybin Extract to UK	20/23/20
Psyence Group Inc. Signs Letter of Intent with INGENu CRO Pty Ltd	09/23/09
Filament Health and Psyence Announce Worldwide Licensing Agreement of Psilocybin Capsule for Palliative Care	15/22/15
Psyence Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	29/22/29
Psyence Group Inc. Announces Resignation of Gavin Basserabie from Board	29/22/29
Psyence Group Inc. with its Joint Venture Partner The Goodleaf Company Ltd Enter into Exclusive Distribution Agreement with This Works Products Limited	29/22/29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Psyence Group Inc.

Equities

PSYG

CA74449Q1063

Other languages

Filters